References
- Kapoor P, Greipp PT, Schaefer EW, et al. Idiopathic systemic capillary leak syndrome (Clarkson’s disease): the Mayo clinic experience. Mayo Clin Proc. 2010;85(10):905–12.
- Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome: etiologies, pathophysiology, and management. Kidney Int. 2017;92(1):37–46. doi:10.1016/j.kint.2016.11.029.
- Rechner I, Brito-Babapulle F, Fielden J. Systemic capillary leak syndrome after granulocyte colony-stimulating factor (G-CSF). Hematol J. 2003;4(1):54. doi:10.1038/sj.thj.6200211.
- Fernandez CV, Mullen EA, Chi YY. Outcome and prognostic factors in stage III favorable-histology Wilms tumor: a report from the children's oncology group study AREN0532. J Clin Oncol. 2017:36(3):254.
- Pearson AD, Pinkerton CR, Lewis IJ, et al. High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial. Lancet Oncol. 2008;9(3):195–196.
- Fariba N, Santana VM, Billups CA, et al. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience. Cancer 2010;106(8):1846–1856. doi:10.1002/cncr.21810.
- Nazir HF, Alfutaisi A, Zacharia M, et al. Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: Frequent autonomic and more severe cranial nerve involvement. Pediatr Blood Cancer 2017;64(12):e26677. doi:10.1002/pbc.26677.
- Pritchard-Jones K, Bergeron C, Camargo BD, et al. Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms’ tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet 2015;386(9999):1156–1164. doi:10.1016/S0140-6736(14)62395-3.
- Verschuur AC, Vujanic GM, Van Tinteren H, et al. Stromal and epithelial predominant Wilms tumours have an excellent outcome: the SIOP 93 01 experience. Pediatr Blood Cancer 2010;55(2):233–238. doi:10.1002/pbc.22496.
- Druey KM, Greipp PR. Narrative review: the systemic capillary leak syndrome. Ann Intern Med. 2010;153(2):90–98. doi:10.7326/0003-4819-153-2-201007200-00005.
- Udayabhaskaran V, Thomas ET, Shaji B. Capillary leak syndrome following snakebite envenomation. Indian J Crit Care Med. 2017;21(10):698–702. doi:10.4103/ijccm.IJCCM_41_17.
- Jeong GH, Lee KH, Lee IR, et al. Incidence of capillary leak syndrome as an adverse effect of drugs in cancer patients: A systematic review and meta-analysis. J Clin Med. 2019;8(2):143. doi:10.3390/jcm8020143.
- Kapoor P, Greipp PT, Schaefer EW, et al. Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. Mayo Clin Proc. 2010;85(10):905–912. doi:10.4065/mcp.2010.0159.
- Biswas S, Nik S, Corrie PG. Severe gemcitabine-induced capillary-leak Syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease. Clin Oncol. 2004; 16(8):577–579. doi:10.1016/j.clon.2004.06.019.
- Druey KM, Greipp PR. Narrative review: Narrative review: the systemic capillary leak syndrome. Ann Intern Med. 2010;153(2):90–98. doi:10.7326/0003-4819-153-2-201007200-00005.
- Velde M, Kaspers GL, Abbink FCH, et al. Vincristine-induced peripheral neuropathy in children with cancer: A systematic review. Crit Rev Oncol Hematol. 2017;114:114. doi:10.1016/j.critrevonc.2017.04.004.
- Al-Homaidhi A, Prince HM, Al-Zahrani H, et al. Granulocyte-macrophage colony-stimulating factor-associated histiocytosis and capillary-leak syndrome following autologous bone marrow transplantation: two case reports and a review of the literature. Bone Marrow Transpl. 1998;21(2):209–214. doi:10.1038/sj.bmt.1701036.
- Hunjan MK, Nowsheen S, Ramos-Rodriguez AJ, et al. Chemotherapy-induced skin toxicity and capillary leak syndrome. Int J Dermatol. 2019;58(7):856. doi:10.1111/ijd.14392.
- Almawi WY, Beyhum HN, Rahme AA, et al. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukoc Biol. 1996;60(5):563–572. doi:10.1002/jlb.60.5.563.
- Hanada M, Sakamoto N, Ishimatsu Y, et al. Effect of long-term treatment with corticosteroids on skeletal muscle strength, functional exercise capacity and health status in patients with interstitial lung disease. Respirology 2016;21(6):1088–1093. doi:10.1111/resp.12807.
- Lambert M, Launay D, E, Morell-Dubois S, et al. High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome. Crit Care Med. 2008;36(7):2184–2187.
- Khalil HA, Belal TS, El-Yazbi AF, et al. The effect of increased lipoproteins levels on the disposition of vincristine in rat. Lipids Health Dis. 2016;15(1):152.